The Discounted Cash Flow (DCF) valuation of Fusion Antibodies PLC (FAB.L) is (41.96) GBP. With the latest stock price at 14.50 GBP, the upside of Fusion Antibodies PLC based on DCF is -389.4%.
Based on the latest price of 14.50 GBP and our DCF valuation, Fusion Antibodies PLC (FAB.L) is a sell. selling FAB.L stocks now will result in a potential gain of 389.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.8% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (92.52) - (27.86) | (41.96) |
| Upside | -738.0% - -292.1% | -389.4% |